Target intelligence / Profile preview

Kinesin family member C1 (KIFC1)

Target
KIFC1
Molecular classification
Motor protein, Kinesin-14 family, Enzyme (ATPase activity), Microtubule-binding protein
01

Overview

Kinesin family member C1 (KIFC1) is a member of the kinesin-14 family of minus-end-directed motor proteins encoded by the KIFC1 gene in humans[1][2]. KIFC1 consists of a C-terminal motor domain with ATPase activity, a superhelical stalk, and an N-terminal tail domain, all containing microtubule-binding regions[1][2]. It is critical for microtubule crosslinking, minus-end-directed movement along microtubules, and, most notably, spindle formation during mitosis by clustering supernumerary centrosomes. This function prevents multipolar spindle formation and aneuploidy, supporting chromosomal stability during cell division[2][4][6]. In cancer, KIFC1 is frequently overexpressed, driving tumor cell proliferation and survival and promoting chemo-resistance and genomic instability[2][3][5][6]. Aberrant activity is a marker of poor prognosis in various tumors and a potential therapeutic target, though its essential physiological roles present safety challenges to drug development targeting KIFC1[2][3][6].

Other names
Kinesin-like protein KIFC1HSETKNSL2Kinesin-like 2Kinesin-related protein HSET
02

Mechanism of action

Inhibition leads to defects in centrosome clustering in cancer cells, resulting in multipolar spindles and cell death[2][3]. Mitotic catastrophe and impaired chromosomal segregation due to loss of spindle assembly function[3].

03

Biological functions

Mitotic spindle assemblyChromosomal segregationMicrotubule crosslinking and slidingGolgi apparatus positioningVesicular and organelle transportSpermiogenesisOocyte development
04

Disease associations

Cancer (including breast, prostate, ovarian, liver, non-small cell lung, endometrial, and esophageal cancers)Tumor proliferation and progressionChemoresistanceNeuronal migration disorders (possible)
05

Safety considerations

Potential off-target toxicity due to roles in normal organelle transport and mitosis in proliferating cells.Adverse effects on normal spermatogenesis, oocyte development, or neurodevelopment due to physiological functions [2][6].Essential function in normal dividing cells may limit therapeutic window.
06

Interacting drugs

No approved drugs directly targeting KIFC1 are currently known.

1 more in the full profile.

07

Biomarkers

High KIFC1 expression (used as a prognostic or diagnostic marker in several cancers, including ESCC and breast cancer)[3][6].

Beyond the preview

Go deeper on Kinesin family member C1 (KIFC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin family member C1 (KIFC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call